254 related articles for article (PubMed ID: 18715782)
21. Structure-activity requirements for flavone cytotoxicity and binding to tubulin.
Beutler JA; Hamel E; Vlietinck AJ; Haemers A; Rajan P; Roitman JN; Cardellina JH; Boyd MR
J Med Chem; 1998 Jun; 41(13):2333-8. PubMed ID: 9632366
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of glucocorticoids on taxol-induced cytotoxicity in human leukemia HL-60 cells.
Pae HO; Yoo JC; Choi BM; Kim TY; Chung HT
Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):439-53. PubMed ID: 10466073
[TBL] [Abstract][Full Text] [Related]
23. Two novel series of allocolchicinoids with modified seven membered B-rings: design, synthesis, inhibition of tubulin assembly and cytotoxicity.
Büttner F; Bergemann S; Guénard D; Gust R; Seitz G; Thoret S
Bioorg Med Chem; 2005 May; 13(10):3497-511. PubMed ID: 15848763
[TBL] [Abstract][Full Text] [Related]
24. Novel antimitotic agents related to tubuloclustin: synthesis and biological evaluation.
Zefirova ON; Nurieva EV; Wobith B; Gogol VV; Zefirov NA; Ogonkov AV; Shishov DV; Zefirov NS; Kuznetsov SA
Mol Divers; 2017 Aug; 21(3):547-564. PubMed ID: 28484934
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.
Chen XX; Gao F; Wang Q; Huang X; Wang D
Fitoterapia; 2014 Jan; 92():111-5. PubMed ID: 24211350
[TBL] [Abstract][Full Text] [Related]
26. Substituted ajoenes as novel anti-cancer agents.
Hunter R; Kaschula CH; Parker IM; Caira MR; Richards P; Travis S; Taute F; Qwebani T
Bioorg Med Chem Lett; 2008 Oct; 18(19):5277-9. PubMed ID: 18774712
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological activity of A-nor-paclitaxel analogues.
Chordia MD; Kingston DG; Hamel E; Lin CM; Long BH; Fairchild CA; Johnston KA; Rose WC
Bioorg Med Chem; 1997 May; 5(5):941-7. PubMed ID: 9208103
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antitumor activity of benzils related to combretastatin A-4.
Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
[TBL] [Abstract][Full Text] [Related]
29. Taxol-induced polymerization of purified tubulin. Mechanism of action.
Kumar N
J Biol Chem; 1981 Oct; 256(20):10435-41. PubMed ID: 6116707
[TBL] [Abstract][Full Text] [Related]
30. Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.
Horvat S; Mlinarić-Majerski K; Glavas-Obrovac L; Jakas A; Veljković J; Marczi S; Kragol G; Roscić M; Matković M; Milostić-Srb A
J Med Chem; 2006 Jun; 49(11):3136-42. PubMed ID: 16722632
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
32. Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
Pettit GR; Toki B; Herald DL; Verdier-Pinard P; Boyd MR; Hamel E; Pettit RK
J Med Chem; 1998 May; 41(10):1688-95. PubMed ID: 9572894
[TBL] [Abstract][Full Text] [Related]
33. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.
Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF
Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844
[TBL] [Abstract][Full Text] [Related]
34. Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2007 Nov; 50(24):6059-66. PubMed ID: 17973361
[TBL] [Abstract][Full Text] [Related]
35. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Nov; 49(23):6656-9. PubMed ID: 17154496
[TBL] [Abstract][Full Text] [Related]
36. Assessment of microtubule stabilizers by semiautomated in vitro microtubule protein polymerization and mitotic block assays.
Lopes NM; Miller HP; Young ND; Bhuyan BK
Cancer Chemother Pharmacol; 1997; 41(1):37-47. PubMed ID: 9443612
[TBL] [Abstract][Full Text] [Related]
37. A novel microtubule depolymerizing colchicine analogue triggers apoptosis and autophagy in HCT-116 colon cancer cells.
Kumar A; Singh B; Sharma PR; Bharate SB; Saxena AK; Mondhe DM
Cell Biochem Funct; 2016 Mar; 34(2):69-81. PubMed ID: 26919061
[TBL] [Abstract][Full Text] [Related]
38. High-throughput screening of microtubule-interacting drugs.
Bane SL; Ravindra R; Zaydman AA
Methods Mol Med; 2007; 137():281-8. PubMed ID: 18085236
[TBL] [Abstract][Full Text] [Related]
39. Enhanced microtubule binding and tubulin assembly properties of conformationally constrained paclitaxel derivatives.
Shanker N; Kingston DG; Ganesh T; Yang C; Alcaraz AA; Geballe MT; Banerjee A; McGee D; Snyder JP; Bane S
Biochemistry; 2007 Oct; 46(41):11514-27. PubMed ID: 17892304
[TBL] [Abstract][Full Text] [Related]
40. N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.
Wang YM; Hu LX; Liu ZM; You XF; Zhang SH; Qu JR; Li ZR; Li Y; Kong WJ; He HW; Shao RG; Zhang LR; Peng ZG; Boykin DW; Jiang JD
Clin Cancer Res; 2008 Oct; 14(19):6218-27. PubMed ID: 18829501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
